The role of 6-acetylmorphine in heroin-induced reward and locomotor sensitization in mice.

Addiction Biology
Anne Marte Sjursen KvelloInger Lise Bogen

Abstract

We have previously demonstrated that heroin's first metabolite, 6-acetylmorphine (6-AM), is an important mediator of heroin's acute effects. However, the significance of 6-AM to the rewarding properties of heroin still remains unknown. The present study therefore aimed to examine the contribution of 6-AM to heroin-induced reward and locomotor sensitization. Mice were tested for conditioned place preference (CPP) induced by equimolar doses of heroin or 6-AM (1.25-5 μmol/kg). Psychomotor activity was recorded during the CPP conditioning sessions for assessment of drug-induced locomotor sensitization. The contribution of 6-AM to heroin reward and locomotor sensitization was further examined by pretreating mice with a 6-AM specific antibody (anti-6-AM mAb) 24 hours prior to the CPP procedure. Both heroin and 6-AM induced CPP in mice, but heroin generated twice as high CPP scores compared with 6-AM. Locomotor sensitization was expressed after repeated exposure to 2.5 and 5 μmol/kg heroin or 6-AM, but not after 1.25 μmol/kg, and we found no correlation between the expression of CPP and the magnitude of locomotor sensitization for either opioid. Pretreatment with anti-6-AM mAb suppressed both heroin-induced and 6-AM-induced CPP and lo...Continue Reading

References

Nov 1, 1992·British Journal of Addiction·M GossopJ Strang
Jan 1, 1995·Neuroscience and Biobehavioral Reviews·M T BardoM J Harris
Sep 1, 1993·Brain Research. Brain Research Reviews·T E Robinson, K C Berridge
Sep 6, 2002·Pharmacology, Biochemistry, and Behavior·Marte HandalJørg Mørland
Feb 1, 2005·Trends in Pharmacological Sciences·Anne-Noël Samaha, Terry E Robinson
Jul 22, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Serge H Ahmed, Martine Cador
May 10, 2007·Nature Protocols·Christopher L CunninghamPeter A Groblewski
Oct 20, 2007·Nature Reviews. Neuroscience·Julie A Kauer, Robert C Malenka
May 9, 2008·Psychopharmacology·Daniele CaprioliAldo Badiani
Jun 27, 2008·Neuroscience Letters·Stefan D SchlussmanMary Jeanne Kreek
Jul 22, 2008·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Terry E Robinson, Kent C Berridge
Aug 22, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Maytal Shabat-SimonAbraham Zangen
Apr 9, 2009·Pharmacology, Biochemistry, and Behavior·Vigdis VindenesJørg Mørland
Jun 3, 2009·Behavioral Neuroscience·Sarah H Meerts, Ann S Clark
Jun 23, 2009·The Journal of Pharmacology and Experimental Therapeutics·Jannike Mørch AndersenJørg Mørland
Oct 29, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Nikhil M UrsMarc G Caron
Dec 17, 2011·Nature Reviews. Immunology·Kim D Janda, Jennifer B Treweek
Jul 5, 2012·Cold Spring Harbor Perspectives in Medicine·Michelle S Mazei-Robison, Eric J Nestler
Dec 12, 2012·The Journal of Pharmacology and Experimental Therapeutics·M D RaleighP R Pentel
Jul 6, 2013·Pharmacology, Biochemistry, and Behavior·Keiichi NiikuraYong Zhang
Oct 1, 2013·Pharmacological Reviews·Gavril W Pasternak, Ying-Xian Pan
Mar 1, 2014·The International Journal of Neuropsychopharmacology·A GottåsJ Mørland
Apr 5, 2014·The Journal of Pharmacology and Experimental Therapeutics·Inger Lise BogenJannike Mørch Andersen
May 13, 2015·British Journal of Pharmacology·John C McGrath, Elliot Lilley
May 25, 2016·The Journal of Pharmacology and Experimental Therapeutics·Anne Marte Sjursen KvelloInger Lise Bogen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved